Two doctors at the National Cancer Centre Singapore (NCCS) have discovered a gene mutation in head and neck cancer patients that, for reasons as yet unknown, results in their responding well to a lung cancer drug.
At least one patient has survived a decade, instead of dying within a few months.
TO READ THE FULL ARTICLE
Thank you for reading The Straits Times
You have reached one of our Premium stories. To continue reading, get access now or log in if you are a subscriber.
What is Premium?